SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for TMDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 218.27M
March 31, 2026 204.53M
December 31, 2025 185.17M
September 30, 2025 180.63M
June 30, 2025 177.27M
March 31, 2025 176.08M
December 31, 2024 168.62M
September 30, 2024 156.27M
June 30, 2024 144.27M
March 31, 2024 130.73M
December 31, 2023 119.55M
September 30, 2023 106.72M
June 30, 2023 92.92M
March 31, 2023 80.94M
December 31, 2022 69.90M
September 30, 2022 60.17M
June 30, 2022 53.66M
March 31, 2022 45.44M
December 31, 2021 38.28M
Date Value
September 30, 2021 32.46M
June 30, 2021 27.62M
March 31, 2021 24.32M
December 31, 2020 24.19M
September 30, 2020 24.18M
June 30, 2020 25.21M
March 31, 2020 25.60M
December 31, 2019 23.60M
September 30, 2019 21.80M
June 30, 2019 18.08M
March 31, 2019 14.72M
December 31, 2018 12.32M
September 30, 2018 9.575M
June 30, 2018 8.589M
March 31, 2018 8.02M
December 31, 2017 7.606M
September 30, 2017 5.972M
June 30, 2017 4.159M
March 31, 2017 1.829M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Alphatec Holdings, Inc. 524.06M
Boston Scientific Corp. 7.159B
Artivion, Inc. 254.77M
Insulet Corp. 1.309B
Teleflex, Inc. 943.66M